没有数据	没有数据

没有数据	没有数据

来源	SDS样本
Matrix	浏览或下载

产品合成路线

更多

名称	CAS号

更多

文章

同行评议文献

Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?N B Sobel Obstetrics and gynecology clinics of North America, 21(2), 299-319 (1994-06-01) [Simultaneous determination of gestodene, etonogestrel and ethinylestradiol in plasma by LC-MS/MS following derivatization].Xiao-Fen Liu et al.Yao xue xue bao = Acta pharmaceutica Sinica, 45(1), 87-92 (2011-03-01) Resumption of ovarian function after 4 years of estro-progestin treatment in a young woman with Crohn's disease and premature ovarian insufficiency: a case report.Ettore Caroppo et al.Journal of assisted reproduction and genetics, 29(9), 973-977 (2012-06-13) Effect of low-dose combined oral contraceptive on aerobic capacity and anaerobic threshold level in active and sedentary young women.Ana Cristina S Rebelo et al.Contraception, 81(4), 309-315 (2010-03-17) Phase of oral contraceptive cycle and endurance capacity of rowers.Sille Vaiksaar et al.Perceptual and motor skills, 113(3), 764-772 (2012-03-13) Use of oral contraceptives containing gestodene and risk of venous thromboembolism: outlook 10 years after the third-generation "pill scare".Lothar A J Heinemann et al.Contraception, 81(5), 401-407 (2010-04-20) Changes in apolipoprotein B100-containing lipoprotein metabolism due to an estrogen plus progestin oral contraceptive: a stable isotope kinetic study.Laurence Duvillard et al.The Journal of clinical endocrinology and metabolism, 95(5), 2140-2146 (2010-03-05) Pharmacokinetics of the new progestogens and influence of gestodene and desogestrel on ethinylestradiol metabolism.F Z Stanczyk Contraception, 55(5), 273-282 (1997-05-01) Cycle control, safety and acceptability of a new oral contraceptive containing ethinylestradiol 15 micrograms and gestodene 60 micrograms.Ladakan Jaithitivit et al.Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 95(5), 630-635 (2012-09-22) [Experience with gestodene-containing hormonal contraceptive].L Szabó et al.Orvosi hetilap, 139(9), 481-485 (1998-04-07) Increased apolipoprotein AI production rate and redistribution of high-density lipoprotein size induced by estrogen plus progestin as oral contraceptive.Laurence Duvillard et al.The Journal of clinical endocrinology and metabolism, 94(12), 4891-4897 (2009-10-28) Hormone-based contraceptive therapy and risk of venous thromboembolism in young women.Helen Roberts Clinical advances in hematology & oncology : H&O, 8(5), 307-309 (2010-06-17) Aromatase gene polymorphism does not influence clinical phenotype and response to oral contraceptive pills in polycystic ovary syndrome women.Polyana S Maier et al.Gynecologic and obstetric investigation, 74(2), 136-142 (2012-08-15) The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.R S London Obstetrical & gynecological survey, 47(11), 777-782 (1992-11-01) Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.U H Winkler American journal of obstetrics and gynecology, 179(3 Pt 2), S51-S61 (1998-09-30) Postoperative depot medroxyprogesterone acetate versus continuous oral contraceptive pills in the treatment of endometriosis-associated pain: a randomized comparative trial.Sopon Cheewadhanaraks et al.Gynecologic and obstetric investigation, 74(2), 151-156 (2012-06-23) Continuous compared with cyclic oral contraceptives for the treatment of primary dysmenorrhea: a randomized controlled trial.Romana Dmitrovic et al.Obstetrics and gynecology, 119(6), 1143-1150 (2012-05-24) Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.Øjvind Lidegaard et al.BMJ (Clinical research ed.), 343, d6423-d6423 (2011-10-27) 17-Hydroxysteroid dehydrogenase type 5 gene polymorphism (-71A/G HSD17B5 SNP) and treatment with oral contraceptive pills in PCOS women without metabolic comorbidities.Polyana S Maier et al.Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 28(8), 606-610 (2012-02-15) Progestin-dependent effect of oral contraceptives on plasma aldosterone/renin ratio.Zoltán Lőcsei et al.Clinical biochemistry, 45(16-17), 1516-1518 (2012-07-04) Activation of NF-kappaB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens.Hugo Maia et al.Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 26(4), 265-269 (2009-09-17) Recurrence rate of endometrioma after laparoscopic cystectomy: a comparative randomized trial between post-operative hormonal suppression treatment or dietary therapy vs. placebo.Francesco Sesti et al.European journal of obstetrics, gynecology, and reproductive biology, 147(1), 72-77 (2009-08-12) New progestins--clinical experiences: gestodene.D Shoupe American journal of obstetrics and gynecology, 170(5 Pt 2), 1562-1568 (1994-05-01) Desogestrel, norgestimate, and gestodene: the newer progestins.B Kaplan The Annals of pharmacotherapy, 29(7-8), 736-742 (1995-07-01) A retrospective case-control study comparing hysteroscopic resection versus hormonal modulation in treating menstrual disorders due to isthmocele.Pasquale Florio et al.Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 27(6), 434-438 (2011-01-06) Gestodene. A review of its pharmacology, efficacy and tolerability in combined contraceptive preparations.M I Wilde et al.Drugs, 50(2), 364-395 (1995-08-01) Continuous low-dose oral contraceptive in the treatment of colorectal endometriosis evaluated by rectal endoscopic ultrasonography.Stefano Ferrari et al.Acta obstetricia et gynecologica Scandinavica, 91(6), 699-703 (2012-01-25) Influence of third-generation oral contraceptives on the complexity analysis and symbolic dynamics of heart rate variability.Ana Cristina Rebelo et al.The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception, 16(4), 289-297 (2011-07-22) Effect of oral contraceptives on markers of hyperandrogenism and SHBG in women with polycystic ovary syndrome.Vincenzo De Leo et al.Contraception, 82(3), 276-280 (2010-08-14) Combined oral contraceptives, venous thromboembolism, and the problem of interpreting large but incomplete datasets.Jürgen Dinger et al.The journal of family planning and reproductive health care, 38(1), 2-6 (2011-12-01) Gestodene-containing contraceptives.H Kuhl et al.Clinical obstetrics and gynecology, 38(4), 829-840 (1995-12-01) Development and validation of UPLC-MS/MS method for simultaneous determination of gestodene and ethinyl estradiol in rat plasma.Zhili Xiong et al.Biomedical chromatography : BMC, 24(2), 160-168 (2009-07-11) Acute and long-term estradiol kinetics in smoking postmenopausal women.N H Bjarnason et al.Climacteric : the journal of the International Menopause Society, 15(5), 449-454 (2011-12-24) Risk of blood clots higher for oral contraceptives with certain progestins.Rebecca Voelker JAMA, 306(20), 2206-2206 (2011-11-24) Clinical aspects of three new progestogens: desogestrel, gestodene, and norgestimate.R A Chez American journal of obstetrics and gynecology, 160(5 Pt 2), 1296-1300 (1989-05-01) Pharmacokinetics of gestodene and ethinyl estradiol after oral administration of a monophasic contraceptive.U Täuber et al.American journal of obstetrics and gynecology, 163(4 Pt 2), 1414-1420 (1990-10-01)

备注